Measurement-specific bioavailable testosterone using concanavalin A precipitation: Comparison of calculated and assayed bioavailable testosterone: Original Article

International Journal of Urology

Volumn 16, Issue 11, 2009, Pages 894-901

  Yamamoto, Kenrou ^a   Koh, Eitetsu ^a   Matsui, Futoshi ^a   Sugimoto, Kazuhiro ^a   Sin, Ho Su ^a   Maeda, Yuji ^a   Namiki, Mikio ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Bioavailable testosterone; Calculated bioavailable testosterone; Concanavalin A; Late onset hypogonadism; SHBG

Indexed keywords

CONCANAVALIN A; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGE; AGED; ARTICLE; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HYPOGONADISM; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; TESTOSTERONE BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BIOLOGICAL AVAILABILITY; CHEMICAL PRECIPITATION; CONCANAVALIN A; HUMANS; MALE; MIDDLE AGED; TESTOSTERONE;

EID: 70350331598     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2009.02379.x     Document Type: Article

References (38)

1. Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J. Clin. Endocrinol. Metab. 1981 53 : 58 68.
2. Stumpf PG, Nakamura RM, Mishell DR Jr. Changes in physiologically free circulating estradiol and testosterone during exposure to levonorgestrel. J. Clin. Endocrinol. Metab. 1981 52 : 138 43.
3. Manni A, Pardridge WM, Cefalu W et al. Bioavailability of albumin-bound testosterone. J. Clin. Endocrinol. Metab. 1985 61 : 705 10.
4. Cumming DC, Wall SR. Non-sex hormone-binding globulin-bound testosterone as a marker for hyperandrogenism. J. Clin. Endocrinol. Metab. 1985 61 : 873 6.
5. Van Berkel GJ, Quirke JM, Adams CL. Derivatization for electrospray ionization-mass spectrometry. 4. Alkenes and alkynes. Rapid Commun. Mass Spectrom. 2000 14 : 849 58.
6. Barrett-Connor E, Von Muhlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 1999 84 : 573 7.
7. Morales A, Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 2002 5 : 74 86.
8. Rosner W. An extraordinarily inaccurate assay for free testosterone is still with us. J. Clin. Endocrinol. Metab. 2001 86 : 2903.
9. Loric S, Guechot J, Duron F, Aubert P, Giboudeau J. Determination of testosterone in serum not bound by sex-hormone-binding globulin: diagnostic value in hirsute women. Clin. Chem. 1988 34 : 1826 9.
10. Tremblay RR, Dube JY. Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception 1974 10 : 599 605.
11. Hammond GL, Lahteenmaki PL. A versatile method for the determination of serum cortisol binding globulin and sex hormone binding globulin binding capacities. Clin. Chim. Acta 1983 132 : 101 10.
12. Morley JE, Kaiser F, Raum WJ et al. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc. Natl. Acad. Sci. USA 1997 94 : 7537 42.
13. Penttila TL, Koskinen P, Penttila TA, Anttila L, Irjala K. Obesity regulates bioavailable testosterone levels in women with or without polycystic ovary syndrome. Fertil. Steril. 1999 71 : 457 61.
14. Dechaud H, Lejeune H, Garoscio-Cholet M, Mallein R, Pugeat M. Radioimmunoassay of testosterone not bound to sex-steroid-binding protein in plasma. Clin. Chem. 1989 35 : 1609 14.
15. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 1999 84 : 3666 72.
16. Miller KK, Rosner W, Lee H et al. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J. Clin. Endocrinol. Metab. 2004 89 : 525 33.
17. Iwamoto T, Yanase T, Horie H, Namiki M, Okuyama A. Late-onset hypogonadism (LOH) and androgens: validity of the measurement of free testosterone levels in the diagnostic criteria in Japan. Int. J. Urol. 2009 16 : 168 74.
18. de Ronde W, van der Schouw YT, Pols HA et al. Calculation of bioavailable and free testosterone in men: a comparison of 5 published algorithms. Clin. Chem. 2006 52 : 1777 84.
19. Grishkovskaya I, Avvakumov GV, Hammond GL, Catalano MG, Muller YA. Steroid ligands bind human sex hormone-binding globulin in specific orientations and produce distinct changes in protein conformation. J. Biol. Chem. 2002 277 : 32086 93.
20. Hammond GL, Avvakumov GV, Muller YA. Structure/function analyses of human sex hormone-binding globulin: effects of zinc on steroid-binding specificity. J. Steroid Biochem. Mol. Biol. 2003 85 : 195 200.
21. Bocchinfuso WP, Warmels-Rodenhiser S, Hammond GL. Expression and differential glycosylation of human sex hormone-binding globulin by mammalian cell lines. Mol. Endocrinol. 1991 5 : 1723 9.
22. Yamashita K, Kobayashi S, Tsukamoto S, Numazawa M. Synthesis of pyridine-carboxylate derivatives of hydroxysteroids for liquid chromatography-electrospray ionization-mass spectrometry. Steroids 2007 72 : 50 9.
23. Power SG, Bocchinfuso WP, Pallesen M, Warmels-Rodenhiser S, Van Baelen H, Hammond GL. Molecular analyses of a human sex hormone-binding globulin variant: evidence for an additional carbohydrate chain. J. Clin. Endocrinol. Metab. 1992 75 : 1066 70.
24. Brotherton J. Estimation of serum sex hormone-binding globulin by five direct and two indirect methods. J. Clin. Lab. Anal. 1990 4 : 405 9.
25. Thalhammer A, Everts I, Hollmann M. Inhibition by lectins of glutamate receptor desensitization is determined by the lectin's sugar specificity at kainate but not AMPA receptors. Mol. Cell. Neurosci. 2002 21 : 521 33.
26. Gonzalez-Sagrado M, Martin-Gil FJ, Lopez-Hernandez S, Fernandez-Garcia N, Olmos-Linares A, Arranz-Pena ML. Reference values and methods comparison of a new testosterone assay on the AxSYM system. Clin. Biochem. 2000 33 : 175 9.
27. Wilke TJ, Utley DJ. Total testosterone, free-androgen index, calculated free testosterone, and free testosterone by analog RIA compared in hirsute women and in otherwise-normal women with altered binding of sex-hormone-binding globulin. Clin. Chem. 1987 33 : 1372 5.
28. Davies R, Collier C, Raymond M, Heaton J, Clark A. Indirect measurement of bioavailable testosterone with the Bayer Immuno 1 system. Clin. Chem. 2002 48 : 388 90.
29. Giton F, Fiet J, Guechot J et al. Serum bioavailable testosterone: assayed or calculated? Clin. Chem. 2006 52 : 474 81.
30. Giton F, Urien S, Born C et al. Determination of bioavailable testosterone [non sex hormone binding globulin (SHBG)-bound testosterone] in a population of healthy French men: influence of androstenediol on testosterone binding to SHBG. Clin. Chem. 2007 53 : 2160 8.
31. Winters SJ, Kelley DE, Goodpaster B. The analog free testosterone assay: are the results in men clinically useful? Clin. Chem. 1998 44 : 2178 82.
32. Emadi-Konjin P, Bain J, Bromberg IL. Evaluation of an algorithm for calculation of serum 'bioavailable' testosterone (BAT). Clin. Biochem. 2003 36 : 591 6.
33. Hajjar RR, Kaiser FE, Morley JE. Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J. Clin. Endocrinol. Metab. 1997 82 : 3793 6.
34. Belgorosky A, Rivarola MA. Changes in serum sex hormone-binding globulin and in serum non-sex hormone-binding globulin-bound testosterone during prepuberty in boys. J. Steroid Biochem. 1987 27 : 291 5.
35. Hayashi T, Yamada T. Association of bioavailable estradiol levels and testosterone levels with serum albumin levels in elderly men. Aging Male 2008 11 : 63 70.
36. Nieschlag E, Swerdloff R, Behre HM et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int. J. Androl. 2005 28 : 125 7.
37. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr. Rev. 2005 26 : 833 76.
38. Namiki M, Akaza H, Shimazui T et al. Clinical practice manual for late-onset hypogonadism syndrome. Int. J. Urol. 2008 15 : 377 88.